1978
DOI: 10.1136/jnnp.41.10.907
|View full text |Cite
|
Sign up to set email alerts
|

Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
13
0
1

Year Published

1980
1980
2002
2002

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 69 publications
(14 citation statements)
references
References 14 publications
0
13
0
1
Order By: Relevance
“…With CSF levels ranging from 17-31% of the plasma level, the CSF concentrations are between 3 and 16 pM (31). These values have to be also evaluated in view of the problems to correlate serum levels of carbamazepine and clinical effects (36).…”
Section: Discussionmentioning
confidence: 99%
“…With CSF levels ranging from 17-31% of the plasma level, the CSF concentrations are between 3 and 16 pM (31). These values have to be also evaluated in view of the problems to correlate serum levels of carbamazepine and clinical effects (36).…”
Section: Discussionmentioning
confidence: 99%
“…The metabolism of CBZ occurs in the liver via a firstorder process. The drug's half-life, after single oral doses in healthy volunteers, was found to be approximately 40 h (8,11,12). In epileptic patients taking the drug chronically, the elimination half-life is shorter (7, 8), by the daily doses given (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…CBZ has been reported to be effective in monotherapy for partial and generalized tonic-clonic seizures in one third to one half (Scheffner et al, 1972;Callaghan et al, 1978) or in 62438% (Shorvon et al, 1978;Schmidt et al, 1983) of patients, including children (Sato et al, 1979;Johnston et al, 1981;Scarpa et al, 1982). Rodin et al (1974) reported that CBZ reduced the frequency of psychomotor seizures by 83% and of grand mal seizures by 55%.…”
Section: Discussionmentioning
confidence: 99%
“…The clinical outcome is most favorable with monotherapy. There are a few reports on CBZ therapy and longterm follow-up data in children (Scheffner et al, 1972;Schain et al, 1977;Callaghan et al, 1978;Sat0 et al, 1979;Scarpa et al, 1982). This is a report of long-term prognosis in children with partial or generalized TCS with or without focal paroxysms on the electroencephalogram (EEG).…”
mentioning
confidence: 99%